Full Professor(heuristic)

Lung Cancer Treatments and Mutations · Pulmonary and Respiratory Medicine

Compare more Pulmonary and Respiratory Medicine professors.

h-index82
i10-index226
Publications826
Citations24,612

Grants

2 total · 0 active

NIH #R01CA203636

Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment

Amount
$600K–$700K
Period
2017-01-012021-12-31
PIs
1

NIH #K23CA157631

CT Volume Measurement of Lung Cancer treated with Erlotinib: Genomic Correlation

Amount
$100K–$200K
Period
2011-09-212016-08-31
PIs
1

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

2 total · 0 active

NIH #R01CA203636

Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment

Amount
$600K–$700K
Period
2017-01-012021-12-31
PIs
1

NIH #K23CA157631

CT Volume Measurement of Lung Cancer treated with Erlotinib: Genomic Correlation

Amount
$100K–$200K
Period
2011-09-212016-08-31
PIs
1

Recent Public Signals

  1. New paper: Presenting features and outcomes to standard systemic therapies in patients with MTAP-deleted advanced non-small cell lung cancer (Clinical Cancer Research)2026-07-06

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-08-24

Data may not be current

Find elsewhere

ORCID: 0000-0003-0275-0502

Professor Insights

Career Trajectory